Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study
- PMID: 27492939
- PMCID: PMC4975020
- DOI: 10.1136/bmj.i4070
Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study
Abstract
Objectives: To compare the risk associated with systolic blood pressure that meets current recommendations (that is, below 140 mm Hg) with the risk associated with lower levels in patients who have type 2 diabetes and no previous cardiovascular disease.
Design: Population based cohort study with nationwide clinical registries, 2006-12. The mean follow-up was 5.0 years.
Setting: 861 Swedish primary care units and hospital outpatient clinics.
Participants: 187 106 patients registered in the Swedish national diabetes register who had had type 2 diabetes for at least a year, age 75 or younger, and with no previous cardiovascular or other major disease.
Main outcome measures: Clinical events were obtained from the hospital discharge and death registers with respect to acute myocardial infarction, stroke, a composite of acute myocardial infarction and stroke (cardiovascular disease), coronary heart disease, heart failure, and total mortality. Hazard ratios were estimated for different levels of baseline systolic blood pressure with clinical characteristics and drug prescription data as covariates.
Results: The group with the lowest systolic blood pressure (110-119 mm Hg) had a significantly lower risk of non-fatal acute myocardial infarction (adjusted hazard ratio 0.76, 95% confidence interval 0.64 to 0.91; P=0.003), total acute myocardial infarction (0.85, 0.72 to 0.99; P=0.04), non-fatal cardiovascular disease (0.82, 0.72 to 0.93; P=0.002), total cardiovascular disease (0.88, 0.79 to 0.99; P=0.04), and non-fatal coronary heart disease (0.88, 0.78 to 0.99; P=0.03) compared with the reference group (130-139 mm Hg). There was no indication of a J shaped relation between systolic blood pressure and the endpoints, with the exception of heart failure and total mortality.
Conclusions: Lower systolic blood pressure than currently recommended is associated with significantly lower risk of cardiovascular events in patients with type 2 diabetes. The association between low blood pressure and increased mortality could be due to concomitant disease rather than antihypertensive treatment.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures
Comment in
-
Hypertension: Blood-pressure lowering in type 2 diabetes.Nat Rev Cardiol. 2016 Oct;13(10):568. doi: 10.1038/nrcardio.2016.137. Epub 2016 Aug 25. Nat Rev Cardiol. 2016. PMID: 27558005 No abstract available.
-
Diabetes: Blood pressure goals in T2DM - time for a rethink?Nat Rev Endocrinol. 2016 Nov;12(11):629-630. doi: 10.1038/nrendo.2016.163. Epub 2016 Sep 30. Nat Rev Endocrinol. 2016. PMID: 27688044 No abstract available.
Similar articles
-
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.BMJ. 2019 Aug 29;366:l4772. doi: 10.1136/bmj.l4772. BMJ. 2019. PMID: 31467044 Free PMC article.
-
Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.Diabet Med. 2014 Sep;31(9):1055-63. doi: 10.1111/dme.12514. Epub 2014 Jun 28. Diabet Med. 2014. PMID: 24894815
-
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.Lancet. 2021 May 1;397(10285):1625-1636. doi: 10.1016/S0140-6736(21)00590-0. Lancet. 2021. PMID: 33933205 Free PMC article.
-
Intensive Blood Pressure Targets for Diabetic and Other High-Risk Populations: A Pooled Individual Patient Data Analysis.Hypertension. 2018 May;71(5):833-839. doi: 10.1161/HYPERTENSIONAHA.117.10713. Epub 2018 Mar 12. Hypertension. 2018. PMID: 29531175 Review.
-
Moderately Elevated Blood Pressure: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Sep. SBU Yellow Report No. 170/1U. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Sep. SBU Yellow Report No. 170/1U. PMID: 28876740 Free Books & Documents. Review.
Cited by
-
Association Between Systolic Blood Pressure and in-Hospital Mortality Among Congestive Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: A Retrospective Cohort Study.Int J Chron Obstruct Pulmon Dis. 2024 Sep 13;19:2023-2034. doi: 10.2147/COPD.S448332. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39291240 Free PMC article.
-
Optimal Antihypertensive Systolic Blood Pressure: A Systematic Review and Meta-Analysis.Hypertension. 2024 Nov;81(11):2329-2339. doi: 10.1161/HYPERTENSIONAHA.124.23597. Epub 2024 Sep 12. Hypertension. 2024. PMID: 39263736
-
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk.Heart. 2023 Jul 27;109(16):1216-1222. doi: 10.1136/heartjnl-2023-322431. Heart. 2023. PMID: 37080767 Free PMC article.
-
Diabetes, Hypertension, and Comorbidity among Bangladeshi Adults: Associated Factors and Socio-Economic Inequalities.J Cardiovasc Dev Dis. 2022 Dec 23;10(1):7. doi: 10.3390/jcdd10010007. J Cardiovasc Dev Dis. 2022. PMID: 36661902 Free PMC article.
-
Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.Hypertension. 2023 Mar;80(3):598-607. doi: 10.1161/HYPERTENSIONAHA.122.20489. Epub 2022 Dec 30. Hypertension. 2023. PMID: 36583386 Free PMC article.
References
-
- Mancia G, Fagard R, Narkiewicz K, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-357. 10.1097/01.hjh.0000431740.32696.cc pmid:23817082. - DOI - PubMed
-
- James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20. 10.1001/jama.2013.284427 pmid:24352797. - DOI - PubMed
-
- American Diabetes Association. Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers. Clin Diabetes 2016;34:3-21. 10.2337/diaclin.34.1.3 pmid:26807004. - DOI - PMC - PubMed
-
- Swedish National Diabetes Register. 20 years of successful improvements. 2016. https://www.ndr.nu/pdfs/20%20years%20of%20successful%20improvements_lowr...
-
- Tancredi M, Rosengren A, Svensson AM, et al. Excess Mortality among Persons with Type 2 Diabetes. N Engl J Med 2015;373:1720-32. 10.1056/NEJMoa1504347 pmid:26510021. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical